Shanghai GenTech Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 1.84%

Shanghai GenTech Co Ltd (688596) has an Asset Resilience Ratio of 1.84% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688596 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

CN¥235.14 Million
≈ $34.41 Million USD Cash + Short-term Investments

Total Assets

CN¥12.80 Billion
≈ $1.87 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how Shanghai GenTech Co Ltd's Asset Resilience Ratio has changed over time. See net asset quality index of Shanghai GenTech Co Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Shanghai GenTech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shanghai GenTech Co Ltd (688596) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥235.14 Million 1.84%
Total Liquid Assets CN¥235.14 Million 1.84%

Asset Resilience Insights

  • Limited Liquidity: Shanghai GenTech Co Ltd maintains only 1.84% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai GenTech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shanghai GenTech Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Vestas Wind Systems A/S
CO:VWS
Specialty Industrial Machinery 0.62%
Nordex SE
F:NDX1
Specialty Industrial Machinery 0.07%
Shenzhen SC New Energy Technology Corp Class A
SHE:300724
Specialty Industrial Machinery 21.03%
Guangdong High Dream Intellectualized Machinery Co Ltd Class A
SHE:300720
Specialty Industrial Machinery 10.02%
Wuxi Boton Technology Co Ltd
SHE:300031
Specialty Industrial Machinery -1.00%
Suzhou TZTEK Technology Co Ltd
SHG:688003
Specialty Industrial Machinery 0.78%
Zhejiang Dayuan Pumps Ind Co
SHG:603757
Specialty Industrial Machinery 3.20%
Shanghai Cooltech Power Co Ltd
SHE:300153
Specialty Industrial Machinery 0.20%

Annual Asset Resilience Ratio for Shanghai GenTech Co Ltd (2020–2025)

The table below shows the annual Asset Resilience Ratio data for Shanghai GenTech Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.55% CN¥200.08 Million
≈ $29.28 Million
CN¥12.95 Billion
≈ $1.89 Billion
+1.17pp
2023-12-31 0.37% CN¥30.06 Million
≈ $4.40 Million
CN¥8.07 Billion
≈ $1.18 Billion
-0.13pp
2022-12-31 0.51% CN¥30.20 Million
≈ $4.42 Million
CN¥5.95 Billion
≈ $871.26 Million
-0.06pp
2021-12-31 0.57% CN¥20.04 Million
≈ $2.93 Million
CN¥3.51 Billion
≈ $513.28 Million
-1.92pp
2020-12-31 2.49% CN¥70.28 Million
≈ $10.28 Million
CN¥2.83 Billion
≈ $413.53 Million
--
pp = percentage points

About Shanghai GenTech Co Ltd

SHG:688596 China Specialty Industrial Machinery
Market Cap
$1.98 Billion
CN¥13.56 Billion CNY
Market Cap Rank
#6349 Global
#1347 in China
Share Price
CN¥46.10
Change (1 day)
-1.50%
52-Week Range
CN¥27.65 - CN¥50.21
All Time High
CN¥50.21
About

Shanghai GenTech Co., Ltd. provides process critical system solutions to customers in hi-tech and advanced manufacturing industries in China. The company offers equipment and system integration process services covering design, manufacturing and installation to hi-tech industries, including IC, flat panel displays, solar photovoltaics, LED, fiber optics, and bio-pharmaceutics. It also produces el… Read more